ADVERTISEMENT

Baby steps to emerging market growth

Baby steps to emerging market growth
Copyright 
By Euronews
Share this articleComments
Share this articleClose Button

$11.8 billion is the price Nestle is going to pay for US firm Pfizer’s infant nutrition business . That is about two billion more than the maximum expected by investors.

In Behind Markets we look at the reasons for the high price and the effects it had.

Click on the link above to see the report

Share this articleComments

You might also like